BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
PPARA
,
Angiogenesis
,
Breast Cancer
,
Retina
,
Laryngoscope
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nicotinic acid adenine dinucleotide phosphate
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
NAADP on target.
N-terminal tagging of two-pore channels interferes with NAADP action.
The N-terminal region of two-pore channel 1 regulates trafficking and activation by NAADP.
Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves th…
Intracellular NAADP increase induced by extracellular NAADP via the P2Y11-like receptor.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Modera…
NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients
Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients
Nicotinamide Riboside in Hospitalized Patients
The Safety and Efficacy Study of RiaGev in Healthy Adults
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ